Alnylam announces that the united kingdom’s mhra grants early access to lumasiran

Alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that the uk’s medicines and healthcare products r

ALNY Ratings Summary

ALNY Quant Ranking